Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation

Denisa Erhartova; Monika Cahova; Helena Dankova; Marie Heczkova; Irena Mikova; Eva Sticova; Julius Spicak; Ondrej Seda; Pavel Trunecka

doi:10.1371/journal.pone.0224820

Loading metrics

Open Access

Peer-reviewed

Research Article

Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation

Denisa Erhartova,

Roles Data curation, Writing – original draft

Affiliations Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, Charles University, First Faculty of Medicine, Institute of Physiology, Prague, Czech Republic

http://orcid.org/0000-0001-6652-653X

⨯
Monika Cahova,

Roles Investigation, Methodology

Affiliation Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯
Helena Dankova,

Roles Investigation

Affiliation Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯
Marie Heczkova,

Roles Investigation

Affiliation Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯
Irena Mikova,

Roles Conceptualization, Methodology, Project administration, Writing – review & editing

Affiliation Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯
Eva Sticova,

Roles Methodology

Affiliation Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯
Julius Spicak,

Roles Supervision

Affiliation Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯
Ondrej Seda,

Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing

Affiliation Charles University and General University Hospital in Prague, First Faculty of Medicine, Institute of Biology and Medical Genetics, Prague, Czech Republic

http://orcid.org/0000-0001-8498-5895

⨯
Pavel Trunecka

Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

* E-mail: patr@ikem.cz

Affiliation Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
⨯

Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation

Denisa Erhartova,
Monika Cahova,
Helena Dankova,
Marie Heczkova,
Irena Mikova,
Eva Sticova,
Julius Spicak,
Ondrej Seda,
Pavel Trunecka

Published: November 8, 2019
https://doi.org/10.1371/journal.pone.0224820

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Steatosis
Is the Subject Area "Steatosis" applicable to this article?

Thanks for your feedback.
Fatty liver
Is the Subject Area "Fatty liver" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Liver transplantation
Is the Subject Area "Liver transplantation" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Lipid metabolism
Is the Subject Area "Lipid metabolism" applicable to this article?

Thanks for your feedback.